Matthew Wagoner

Senior Director, Head of Investigative Toxicology
Takeda Development Center Americas

Presentation(s):

• PB0211 - A translational analysis of immune components in peripheral blood from severe hemophilia A patients treated with TAK-754, an AAV8 vector with a codon-optimized B-domain–deleted factor VIII transgene

  Sunday, July 10, 2022
  6:30 PM – 7:30 PM